Ad
related to: national antidepressant statistics survey pdf fillable
Search results
Results From The WOW.Com Content Network
The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018. [1]The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults". [2]
The World Health Organization Composite International Diagnostic Interview (CIDI) is a structured interview for psychiatric disorders.As the interview is designed for epidemiological studies, it can be administered by those who are not clinically trained and can be completed in a short amount of time.
The Montgomery–Åsberg Depression Rating Scale (MADRS) is a ten-item [1] diagnostic questionnaire which mental health professionals use to measure the severity of depressive episodes in patients with mood disorders.
The National Comorbidity Survey: Reinterview (NCS-2) was a follow-up study conducted between 2001 and 2002. The participants in NCS-1 were re-interviewed with the aim to collect information about changes in mental disorders, substance use disorders , and the predictors and consequences of these changes over the ten years between the two surveys.
Some depression rating scales are completed by patients. The Beck Depression Inventory, for example, is a 21-question self-report inventory that covers symptoms such as irritability, fatigue, weight loss, lack of interest in sex, and feelings of guilt, hopelessness or fear of being punished. [11]
"The Hamilton Rating Scale for Depression" (PDF). Archived from the original (PDF) on 2007-11-20 (49.0 KB) Clinically Useful Psychiatric Scales: HAM-D (Hamilton Depression Rating Scale). Accessed March 6, 2009. Hamilton Depression Rating Scale - Original scientific paper published in 1960 in Psychiatry out of Print website. Accessed June 27, 2008.
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) was a collaborative study on the treatment of depression, funded by the National Institute of Mental Health. Its main focus was on the treatment of depression in patients where the first prescribed antidepressant proved inadequate.
Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of psychiatric drugs used primarily as antidepressants. [1] They act by antagonizing the α 2 -adrenergic receptor and certain serotonin receptors such as 5-HT 2A and 5-HT 2C , [ 1 ] but also 5-HT 3 , [ 1 ] 5-HT 6 , and/or 5-HT 7 in some cases.